clindamycin and Malignant Melanoma

clindamycin has been researched along with Malignant Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anforth, R; Clements, A; Fernandez-Peñas, P; Kefford, R; Liu, M; Long, GV; Nguyen, B; Uribe, P	1

Other Studies

1 other study(ies) available for clindamycin and Malignant Melanoma

Article	Year
Acneiform eruptions: a common cutaneous toxicity of the MEK inhibitor trametinib. The Australasian journal of dermatology, 2014, Volume: 55, Issue:4 Topics: Acneiform Eruptions; Administration, Cutaneous; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antineoplastic Combined Chemotherapy Protocols; Clindamycin; Clinical Trials as Topic; Doxycycline; Drug Eruptions; Female; Humans; Imidazoles; Male; Melanoma; Middle Aged; Oximes; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; Retrospective Studies; Skin Neoplasms; Triclosan	2014

Article

Year

Acneiform eruptions: a common cutaneous toxicity of the MEK inhibitor trametinib.

The Australasian journal of dermatology, 2014, Volume: 55, Issue:4

Topics: Acneiform Eruptions; Administration, Cutaneous; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antineoplastic Combined Chemotherapy Protocols; Clindamycin; Clinical Trials as Topic; Doxycycline; Drug Eruptions; Female; Humans; Imidazoles; Male; Melanoma; Middle Aged; Oximes; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; Retrospective Studies; Skin Neoplasms; Triclosan

2014